Gene · 9833
Papers1,515
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,515
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ANKRD22 promotes glioma proliferation, migration, invasion, and epithelial-mesenchymal transition by upregulating E2F1-mediated MELK expression. | J Neuropathol Exp Neurol | 2023 | 37164633 | PubTator, text mining | PubMed |
| AURKA, TOP2A and MELK are the key genes identified by WGCNA for the pathogenesis of lung adenocarcinoma. | Oncol Lett | 2023 | 37153047 | PubTator, text mining | PubMed |
| Genetic characteristics and clinical-specific survival prediction in elderly patients with gallbladder cancer: a genetic and population-based study. | Front Endocrinol (Lausanne) | 2023 | 37152947 | PubTator, text mining | PubMed |
| TRA2: The dominant power of alternative splicing in tumors. | Heliyon | 2023 | 37151663 | PubTator, text mining | PubMed |
| A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer. | Medicine (Baltimore) | 2023 | 37145007 | PubTator, text mining | PubMed |
| Interactions between curcumin and human salt-induced kinase 3 elucidated from computational tools and experimental methods. | Front Pharmacol | 2023 | 37124223 | PubTator, text mining | PubMed |
| Integrated Covalent Drug Design Workflow Using Site Identification by Ligand Competitive Saturation. | J Chem Theory Comput | 2023 | 37115781 | PubTator, text mining | PubMed |
| A Mixture Method for Robust Detection HCV Early Diagnosis Biomarker with ML Approach and Molecular Docking. | Int J Mol Sci | 2023 | 37108370 | PubTator, text mining | PubMed |
| Assessing Breast Cancer Molecular Subtypes Using Extracellular Vesicles' mRNA. | Anal Chem | 2023 | 37071799 | PubTator, text mining | PubMed |
| Comprehensive analysis of the expression and prognosis for RAI2: A promising biomarker in breast cancer. | Front Oncol | 2023 | 37064084 | PubTator, text mining | PubMed |
| Uncovering a novel role of focal adhesion and interferon-gamma in cellular rejection of kidney allografts at single cell resolution. | Front Immunol | 2023 | 37063857 | PubTator, text mining | PubMed |
| Risk factors and actionable molecular signatures in COVID-19-associated lung adenocarcinoma and lung squamous cell carcinoma patients. | Comput Biol Med | 2023 | 37040675 | PubTator, text mining | PubMed |
| Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases. | Signal Transduct Target Ther | 2023 | 37029108 | PubTator, text mining | PubMed |
| MiR-4521 perturbs FOXM1-mediated DNA damage response in breast cancer. | Front Mol Biosci | 2023 | 37025658 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1. | Biochem J | 2023 | 37018014 | PubTator, text mining | PubMed |
| miR-21-5p Inhibits Ferroptosis in Hepatocellular Carcinoma Cells by Regulating the AKT/mTOR Signaling Pathway through MELK. | J Immunol Res | 2023 | 37008632 | PubTator, text mining | PubMed |
| Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer. | Front Genet | 2023 | 37007961 | PubTator, text mining | PubMed |
| Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer. | Drug Des Devel Ther | 2023 | 36998242 | PubTator, text mining | PubMed |
| Identification of Selection Signatures and Loci Associated with Important Economic Traits in Yunan Black and Huainan Pigs. | Genes (Basel) | 2023 | 36980926 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9833/papers?page=12